RYZ101 (225Ac-DOTATATE) + Carboplatin + Etoposide + Atezolizumab in Somatostatin Receptor Expressing Extensive-Stage Small-Cell Lung Cancer

Authors

S Puri
W Akerley
R Langdon
S Mehr
N Rivera-Rodriguez
J Berilgen
J M. Rineer
C Mulvey
Krisha Howell, Corewell Health
Manish Thakur, Corewell Health West

Document Type

Conference Proceeding

Publication Date

10-2024

Publication Title

Journal of Thoracic Oncology

Volume

19

Issue

10 Suppl

First Page

S210

Recommended Citation

Puri S, Akerley W, Langdon R, Mehr S, Rivera-Rodriguez N, Berilgen J, et al. [Howell K, Thakur M]. RYZ101 (225Ac-DOTATATE) + carboplatin + etoposide + atezolizumab in somatostatin receptor expressing extensive-stage small-cell lung cancer. J Thorac Oncol. 2024 Oct;19(10 Suppl):S210. doi:10.1016/j.jtho.2024.09.378

Comments

2024 World Conference on Lung Cancer, September 7-10, 2024, San Diego, CA

DOI

10.1016/j.jtho.2024.09.378